Stay updated on Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the lapse-in-government-funding notice (and the previous Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a top-of-page notice about potential delays due to a lapse in government funding and directing users to cc.nih.gov and opm.gov for updates. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedThe page now includes a visible 'Show glossary' control and displays a new 'Last Update Submitted that Met QC Criteria' timestamp, a 'No FEAR Act Data' notice, and a 'Revision: v3.4.0' label. The previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' entries were removed.SummaryDifference0.1%

- Check42 days agoChange DetectedSite revision updated: Revision v3.3.4 was added and Revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section reorganized to consolidate site listings under a single Locations heading with state subsections (Alabama, California, District of Columbia, Florida, Georgia, Illinois, Kentucky, Michigan, North Carolina, Oregon, Pennsylvania, Texas, Utah, Virginia, Wisconsin). Revision updated to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.